Showing results (131-140 of 226) with videos related to

Sort By:
Pageof 23
Blood|May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studiesDennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Journal of Computer Assisted Tomography|November 25, 2015
Computed Tomography Observer Agreement in Staging Malignant LymphomaAntoinette de Jong, Thomas C Kwee, Henriëtte M E Quarles van Ufford, et al.
EJNMMI Research|February 15, 2024
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PETJessica E Wijngaarden, Yvonne W S Jauw, Gerben J C Zwezerijnen, et al.
BMC Palliative Care|October 25, 2019
Efficacy and cost-utility of the eHealth application 'Oncokompas', supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled trialAnouk S Schuit, Karen Holtmaat, Nienke Hooghiemstra, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2025
Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristicsEline M J Lammers, Berthe M P Aleman, Michael Schaapveld, et al.
Hemasphere|June 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-upDennis A Eichenauer, Marc André, Peter Borchmann, et al.
Blood|April 18, 2014
Risk of multiple primary malignancies following treatment of Hodgkin lymphomaAnna M van Eggermond, Michael Schaapveld, Pieternella J Lugtenburg, et al.
Ejhaem|September 2, 2022
Blood-circulating EV-miRNAs, serum TARC, and quantitative FDG-PET features in classical Hodgkin lymphomaEsther E E Drees, Julia Driessen, Gerben J C Zwezerijnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2022
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic IndexN George Mikhaeel, Martijn W Heymans, Jakoba J Eertink, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2021
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell LymphomaMje Greuter, J J Eertink, G Jongeneel, et al.
Pageof 23